PL BioScience GmbH | WebDisclosure

PRESS RELEASE

published on 06/11/2025 at 10:00, 1 year 2 months ago

PL BioScience Strengthens Management Team with Appointment of Oliver Dick as Chief Technology Officer
PL BioScience strengthens management team with appointment of Oliver Dick as Chief Technology Officer. Oliver Dick brings 30 years of expertise in life science, diagnostic, and biopharma operations

Chief Technology Officer Biopharmaceutical Life Science PL BioScience Oliver Dick
BRIEF

published on 05/19/2025 at 15:05, 1 year 3 months ago

PL BioScience et DewCell s'associent pour développer des plaquettes humaines artificielles

Plaquettes Artificielles Milieux De Culture Cellulaire Développement HPL Solutions Sans Animaux Collaboration Biotechnologique
BRIEF

published on 05/19/2025 at 15:05, 1 year 3 months ago

PL BioScience and DewCell Partner on Artificial Human Platelets

Biotech Collaboration Artificial Platelets Cell Culture Media HPL Development Animal-free Solutions
PRESS RELEASE

published on 05/19/2025 at 15:00, 1 year 3 months ago

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media
PL BioScience and DewCell sign LOI to jointly develop artificial human platelets for scalable, animal-free cell culture media. The collaboration aims to meet demand driven by regulatory trends in cell- and gene therapy development

PL BioScience Cell Culture Media DewCell Artificial Human Platelets Regulatory Trends
BRIEF

published on 05/08/2025 at 14:05, 1 year 3 months ago

PL BioScience dévoile le premier lysat plaquettaire humain artificiel au monde

Médecine Régénérative Produits Biopharmaceutiques Culture Cellulaire PL BioScience HPL Artificiel
BRIEF

published on 05/08/2025 at 14:05, 1 year 3 months ago

PL BioScience Unveils World's First Artificial Human Platelet Lysate

Regenerative Medicine Biopharmaceuticals Cell Culture PL BioScience Artificial HPL
PRESS RELEASE

published on 05/08/2025 at 14:00, 1 year 3 months ago

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
PL BioScience GmbH introduces first artificial Human Platelet Lysate (HPL) worldwide, revolutionizing cell culture technology for biopharmaceutical applications

Biopharmaceutical Human Platelet Lysate PL BioScience Artificial Cell Culture Technology
BRIEF

published on 04/30/2025 at 12:05, 1 year 3 months ago

PL BioScience Unveils Unique Gamma-irradiated Human Platelet Lysate

Regenerative Medicine Cell Therapy Human Platelet Lysate Gamma-Irradiation Xeno-Free Supplement
BRIEF

published on 04/30/2025 at 12:05, 1 year 3 months ago

PL BioScience dévoile un lysat plaquettaire humain unique irradié aux rayons gamma

Médecine Régénérative Thérapie Cellulaire Lysat Plaquettaire Humain Irradiation Gamma Supplément Sans Xénobiotiques
PRESS RELEASE

published on 04/30/2025 at 12:00, 1 year 3 months ago

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
PL BioScience launches ELAREM™ Ultimate-FD PLUS, the only gamma-irradiated, GMP-grade Human Platelet Lysate in Europe. The product offers a safer, sustainable, virus-inactivated, and animal-free alternative for cell manufacturing applications

GMP-grade Human Platelet Lysate PL BioScience ELAREM Ultimate-FD PLUS Gamma-irradiated

Published on 08/22/2026 at 05:50, 14 hours 40 minutes ago

Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 15 hours 35 minutes ago

Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 20 hours ago

BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 21 hours 30 minutes ago

Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 21 hours 30 minutes ago

Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott

View all ACCESSWIRE

Published on 08/21/2026 at 19:36, 1 day ago

EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 1 day 1 hour ago

EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 18:14, 1 day 2 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/21/2026 at 17:27, 1 day 3 hours ago

EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 1 day 4 hours ago

BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades

View all EQS

Published on 08/21/2026 at 18:33, 1 day 1 hour ago

260821 BENETEAU Transaction sur actions propres
Published on 08/21/2026 at 08:30, 1 day 12 hours ago

Thales issues a €1bn bond
Published on 08/21/2026 at 08:30, 1 day 12 hours ago

Thales émet un emprunt obligataire de 1 Md€
Published on 08/18/2026 at 18:00, 4 days 2 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 4 days 2 hours ago

Mise à disposition du rapport financier annuel 2025-26

View all LES ECHOS COMFI WIRE

News